Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: A prospective single-arm study

International Journal of Clinical Oncology

Volumn 18, Issue 4, 2013, Pages 724-730

  Koie, Takuya ^a   Ohyama, Chikara ^a   Hashimoto, Yasuhiro ^a   Hatakeyama, Shingo ^a   Yamamoto, Hayato ^a   Yoneyama, Takahiro ^a   Kamimura, Noritaka ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Carboplatin; Gemcitabine; Neoadjuvant chemotherapy; Radical cystectomy; Urothelial carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADULT; AGED; ALOPECIA; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LEUKOPENIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE BLADDER CANCER; NAUSEA; NEUTROPENIA; PATIENT IDENTIFICATION; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; URTICARIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARBOPLATIN; CISPLATIN; CYSTECTOMY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84882605969     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0447-z     Document Type: Article

References (26)

1. Raghavan D, Shipley WU, Hall RR et al (1997) Biology and management of invasive bladder cancer. In: Raghavan D, Scher HI (eds) Principles and practice of genitourinary oncology. Lippincott-Ravel, Philadelphia, pp 281-298
2. Ghonheim MA, El-Mekresh MM, Mokhtar AA et al (2000) A predictive model of survival after radical cystectomy for carcinoma of the bladder. BJU Int 85:811-816
3. Grossman HB, Natale RB, Tangen CM et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Eng J Med 349:859-866
4. David KA, Milowsky MI, Ritchey J et al (2007) Low incidence of perioperative chemotherapy for stage III bladder cancer 1998-2003: a report from the National Cancer Data Base. J Urol 178:451-454
5. Loehrer P, Einhorn LH, Elson PJ et al (1992) A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a Cooperative Group Study. J Clin Oncol 10:1066-1073
6. Mamhmud S, Fong B, Fahmy N et al (2006) Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 175:78-83
7. Weight CJ, Garcia JA, Hansel DE et al (2009) Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer 115:792-799
8. von der Masse H, Sengelov L, Roberts JT et al (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large randomized, multicenter, multinational, multicenter, phase III study. J Clin Oncol 18:3068-8077
9. von der Masse H, Sengelov L, Roberts JT et al (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23:4602-4608
10. Dash A, Pettus JA IV, Herr HW et al (2008) A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer 113:24712477
11. International Collaboration of Trial on behalf of the Medical Research Council Advanced Bladder Cancer Working Party (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 29:2171-2177
12. Bellmunt J, Ribas A, Eres N et al (1997) Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer 80:1966-1972
13. Bamias A, Moulopoulos LA, Koutras A et al (2006) The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group. Cancer 106:297-303
14. Galsky MD, Hahn NM, Rosenberg G et al (2011) Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based chemotherapy. J Clin Oncol 14:2432-2438
15. Calvert AH, Newell DR, Gumbrell LA et al (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756
16. Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
17. Life expectancy and mortality (2011). In: World health statistics 2011, World health organization press, Geneva, pp 45-55
18. Koie T, Yamamoto H, Okamoto A et al (2009) Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer. J Clin Oncol 27(suppl):e16100
19. Ranaldi M, Crino L, Scagliotti GV et al (2000) A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial. Ann Oncol 11:1295-1300
20. Para HS, Caviuna R, Latteri F et al (2004) Tree-week versus four-week schedule of cisplatin and gemcitabine: results of randomized phase II study. Ann Oncol 13:1080-1086
21. Ando Y, Minami H, Saka H et al (1997) Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing. Br J Cancer 76:1067-1071
22. Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361:1927-1934
23. No authors listed (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomized controlled trial. International collaboration of trialists. Lancet 354:533-540
24. Scosyrev E, Messing EM, van Wijngaarden E et al (2012) Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer 118:72-81
25. Shannon C, Crombie C, Brooks A et al (2001) Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic feature. Ann Oncol 12:947-952
26. Linardou H, Aravantinos G, Efstathiou E et al (2004) Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: phase II study of the Hellenic co-operative oncology group. Urology 64:479-484